These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14747215)

  • 21. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
    Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.
    Maynard JD; Rohrscheib M; Way JF; Nguyen CM; Ediger MN
    Diabetes Care; 2007 May; 30(5):1120-4. PubMed ID: 17337498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
    Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
    Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].
    Zhang YL; Guo SQ; Ma WB; Wang J; Bai GQ; Yang Q; Ti SF; Ma R; Wei RP; Liu WX; Li Z; Yang L; Liu DW; Li ZH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1174-8. PubMed ID: 21162825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
    Nair M; Prabhakaran D; Narayan KM; Sinha R; Lakshmy R; Devasenapathy N; Daniel CR; Gupta R; George PS; Mathew A; Tandon N; Reddy KS
    Prim Care Diabetes; 2011 Jul; 5(2):95-102. PubMed ID: 21474403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of HbA1c and OGTT for the diagnosis of type 2 diabetes in children at risk of diabetes.
    Kim MS; Jo DS; Lee DY
    Pediatr Neonatol; 2019 Aug; 60(4):428-434. PubMed ID: 30497969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of HbA1c combined FPG on screening diabetes in health check-up.
    Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
    Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose.
    Cypryk K; Czupryniak L; Wilczyński J; Lewiński A
    Acta Diabetol; 2004 Mar; 41(1):5-8. PubMed ID: 15057547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting.
    Gray LJ; Davies MJ; Hiles S; Taub NA; Webb DR; Srinivasan BT; Khunti K
    Diabetologia; 2012 Apr; 55(4):959-66. PubMed ID: 22231125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
    Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
    Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand.
    Sitasuwan T; Lertwattanarak R
    BMJ Open; 2020 Nov; 10(11):e041269. PubMed ID: 33172945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HbA1c predicts the likelihood of having impaired glucose tolerance in high-risk patients with normal fasting plasma glucose.
    Geberhiwot T; Haddon A; Labib M
    Ann Clin Biochem; 2005 May; 42(Pt 3):193-5. PubMed ID: 15949153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does HbA1C predict isolated impaired fasting glycaemia in the oral glucose tolerance test in subjects with impaired fasting glycaemia?
    Likhari T; Aulakh TS; Singh BM; Gama R
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):418-20. PubMed ID: 18583629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of stable HbA(1c) for supportive marker to diagnose diabetes mellitus in Japanese subjects.
    Tanaka Y; Atsumi Y; Matsuoka K; Mokubo A; Asahina T; Hosokawa K; Shimada S; Matsunaga H; Takagi M; Ogawa O; Onuma T; Kawamori R
    Diabetes Res Clin Pract; 2001 Jul; 53(1):41-5. PubMed ID: 11378212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irish diabetes detection programme in general practice.
    Smith SM; Holohan J; McAuliffe A; Firth RG
    Diabet Med; 2003 Sep; 20(9):717-22. PubMed ID: 12925050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of fasting plasma glucose values for optimal detection of abnormal responses on the oral glucose tolerance test in at-risk study subjects.
    Robles-Osorio L; Aguilar-Salinas CA; Mehta R; Gómez-Pérez FJ; Rull JA
    Endocr Pract; 2007 Oct; 13(6):583-9. PubMed ID: 17954413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral glucose tolerance testing as a complement to fasting plasma glucose in screening for type 2 diabetes: population-based cross-sectional analyses of 146 000 health examinations in Västerbotten, Sweden.
    Rosén A; Otten J; Stomby A; Vallin S; Wennberg P; Brunström M
    BMJ Open; 2022 Jun; 12(6):e062172. PubMed ID: 35676014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.